Terms: = Liver cancer AND ETV4, PEA3, 2118, ENSG00000175832, E1AF, E1A-F, PEAS3
32 results:
1. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
[TBL] [Abstract] [Full Text] [Related]
2. Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments.
Zheng J; Liang X; Wu AGR; Kabir T; Scatton O; Lim C; Hasegawa K; Sijberden JP; Aghayan DL; Siow TF; Dokmak S; Herman P; Marino MV; Mazzaferro V; Chiow AKH; Sucandy I; Ivanecz A; Choi SH; Lee JH; Prieto M; Vivarelli M; Giuliante F; Ruzzenente A; Yong CC; Yin M; Chen Z; Fondevila C; Efanov M; Morise Z; Di Benedetto F; Brustia R; Dalla Valle R; Boggi U; Geller D; Belli A; Memeo R; Gruttadauria S; Mejia A; Park JO; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Pratschke J; Lai ECH; Chong CCN; D'Hondt M; Monden K; Lopez-Ben S; Kingham TP; Ferrero A; Ettorre GM; Cherqui D; Cipriani F; Soubrane O; Zhang W; Wakabayashi G; Troisi RI; Cheung TT; Kato Y; Sugioka A; Long TCD; Liu R; Edwin B; Fuks D; Abu Hilal M; Chen KH; Aldrighetti L; Han HS; Goh BKP;
Eur J Surg Oncol; 2024 Jan; 50(1):107252. PubMed ID: 37984243
[TBL] [Abstract] [Full Text] [Related]
3. etv4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
Su H; Shu S; Tang W; Zheng C; Zhao L; Fan H
Biochem Biophys Res Commun; 2023 Dec; 684():149137. PubMed ID: 37897911
[TBL] [Abstract] [Full Text] [Related]
4. Transcription factor etv4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
[TBL] [Abstract] [Full Text] [Related]
5. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor etv4 up-regulates PHLDA2 to promote the growth of liver cancer.
Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
[TBL] [Abstract] [Full Text] [Related]
6. FGF19/FGFR4-mediated elevation of etv4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2.
Xie M; Lin Z; Ji X; Luo X; Zhang Z; Sun M; Chen X; Zhang B; Liang H; Liu D; Feng Y; Wang Y; Li Y; Liu B; Huang W; Xia L
J Hepatol; 2023 Jul; 79(1):109-125. PubMed ID: 36907560
[TBL] [Abstract] [Full Text] [Related]
7. Hepatitis C Virus Core Protein Promotes the Metastasis of Human Hepatocytes by Activating the MAPK/ERK/pea3-SRF/c-Fos/MMPs Axis.
Zhao L; Sun X; Chen L; Feng X; Yang X; Zou P; Wang X; Zhang R
Arch Med Res; 2022 Jul; 53(5):469-482. PubMed ID: 35817647
[TBL] [Abstract] [Full Text] [Related]
8. Palliative radiotherapy for multiple liver metastases: a retrospective analysis of 73 cases.
Ito K; Ogoshi Y; Shimizuguchi T
Jpn J Clin Oncol; 2022 Jul; 52(7):779-784. PubMed ID: 35396600
[TBL] [Abstract] [Full Text] [Related]
9. etv4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.
Xu X; Wang B; Liu Y; Jing T; Xu G; Zhang L; Kun Jiao ; Chen Z; Xiang L; Xu C; Yang Z; Liu Y
Cancer Lett; 2022 Jul; 537():215640. PubMed ID: 35296440
[TBL] [Abstract] [Full Text] [Related]
10. HBx increases chromatin accessibility and etv4 expression to regulate dishevelled-2 and promote HCC progression.
Zheng C; Liu M; Ge Y; Qian Y; Fan H
Cell Death Dis; 2022 Feb; 13(2):116. PubMed ID: 35121725
[TBL] [Abstract] [Full Text] [Related]
11. etv4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression.
Sun T; Zhang J
J Biochem; 2021 Dec; 170(5):663-673. PubMed ID: 34347084
[TBL] [Abstract] [Full Text] [Related]
12. Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells.
Liu Y; Xue M; Cao D; Qin L; Wang Y; Miao Z; Wang P; Hu X; Shen J; Xiong B
Genomics; 2021 May; 113(3):1057-1069. PubMed ID: 33667649
[TBL] [Abstract] [Full Text] [Related]
13. Sustained-hepatic arterial infusion of oxaliplatin: pharmacokinetic advantages over hepatic arterial infusion using a preclinical animal tumour model.
Deschamps F; Tselikas L; Tasaki M; Motoyama S; Isoardo T; Ducreux M; Paunovic D; Moine L; de Baere T
Drug Deliv Transl Res; 2021 Oct; 11(5):2144-2150. PubMed ID: 33432522
[TBL] [Abstract] [Full Text] [Related]
14. [E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells
Xiaohui C; Xin LI; Dehua WU
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):875-882. PubMed ID: 31511205
[TBL] [Abstract] [Full Text] [Related]
15. PBK overexpression promotes metastasis of hepatocellular carcinoma via activating etv4-uPAR signaling pathway.
Yang QX; Zhong S; He L; Jia XJ; Tang H; Cheng ST; Ren JH; Yu HB; Zhou L; Zhou HZ; Ren F; Hu ZW; Gong R; Huang AL; Chen J
Cancer Lett; 2019 Jun; 452():90-102. PubMed ID: 30914208
[TBL] [Abstract] [Full Text] [Related]
16. Near-Comprehensive Resequencing of cancer-Associated Genes in Surgically Resected Metastatic liver Tumors of Gastric cancer.
Ikari N; Serizawa A; Mitani S; Yamamoto M; Furukawa T
Am J Pathol; 2019 Apr; 189(4):784-796. PubMed ID: 30703342
[TBL] [Abstract] [Full Text] [Related]
17. Contemporary practice and short-term outcomes after liver resections in a complete national cohort.
Lassen K; Nymo LS; Olsen F; Brudvik KW; Fretland ÅA; Søreide K
Langenbecks Arch Surg; 2019 Feb; 404(1):11-19. PubMed ID: 30519886
[TBL] [Abstract] [Full Text] [Related]
18. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
[TBL] [Abstract] [Full Text] [Related]
19. [D2 radical resection of omental bursa and No.12p and No.8p for gastric carcinoma: a retrospectively analysis from a single center in China].
Chen L; Wei S; Ye Z; Xiao J; Zeng Y; Wang Y; Lin Z; Lin Z; Chen X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):196-200. PubMed ID: 29492920
[TBL] [Abstract] [Full Text] [Related]
20. Capicua suppresses hepatocellular carcinoma progression by controlling the etv4-MMP1 axis.
Kim E; Kim D; Lee JS; Yoe J; Park J; Kim CJ; Jeong D; Kim S; Lee Y
Hepatology; 2018 Jun; 67(6):2287-2301. PubMed ID: 29251790
[TBL] [Abstract] [Full Text] [Related]
[Next]
